January 11, 2022
Buy – Sell – Short
Over the years Diabetic Investor has been reluctant to make specific recommendations on when to buy, sell or short a company. Yes, we have ventured down this path and thankfully more often than not our recommendations have yielded a handsome profit. Yet unlike a traditional analyst or stock picker we pay more attention to who’s running the company and the market it plays in than the day-to-day financials. As we have noted many times the company with the most talent usually wins and in our wacky world talent is in short supply.
Now unless you have been . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.